0000899243-20-010502.txt : 20200408
0000899243-20-010502.hdr.sgml : 20200408
20200408160027
ACCESSION NUMBER: 0000899243-20-010502
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20200406
FILED AS OF DATE: 20200408
DATE AS OF CHANGE: 20200408
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Rolfe Lindsey
CENTRAL INDEX KEY: 0001650504
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-35347
FILM NUMBER: 20782028
MAIL ADDRESS:
STREET 1: C/O CLOVIS ONCOLOGY, INC.
STREET 2: 499 ILLINOIS STREET, SUITE 200
CITY: SAN FRANCISCO
STATE: CA
ZIP: 94158
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Clovis Oncology, Inc.
CENTRAL INDEX KEY: 0001466301
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 900475355
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 5500 FLATIRON PARKWAY
STREET 2: SUITE 100
CITY: BOULDER
STATE: CO
ZIP: 80301
BUSINESS PHONE: (303) 625-5000
MAIL ADDRESS:
STREET 1: 5500 FLATIRON PARKWAY
STREET 2: SUITE 100
CITY: BOULDER
STATE: CO
ZIP: 80301
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2020-04-06
0
0001466301
Clovis Oncology, Inc.
CLVS
0001650504
Rolfe Lindsey
C/O CLOVIS ONCOLOGY, INC.
5500 FLATIRON PARKWAY, SUITE 100
BOULDER
CO
80301
0
1
0
0
See Remarks
Common Stock
2020-04-06
4
M
0
23034
3.08
A
59091
D
Common Stock
2020-04-06
4
F
0
16733
6.80
D
42358
D
Employee Stock Option (right to buy)
3.08
2020-04-06
4
M
0
23034
0.00
D
2020-04-07
Common Stock
23034
0
D
The option vested as to 25% of the shares on April 1, 2011, and the remainder vested in substantially equal installments over the 36 months immediately following such date.
Chief Medical Officer and Executive Vice President of Clinical and Preclinical Development and Pharmacovigilance
/s/ Lindsey Rolfe
2020-04-08